Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

REENE NAIDOO DOUGLAS

Allopathic & Osteopathic Physicians Pediatrics

NPI
1861652281
CMS profile
1320099
Location
HUMBLE, TX

General Payments · PY2018–2024

$1,186.64

  • Reported across 69 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$268.00

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $268.00 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $86.17 5
PFIZER INC. $70.55 3
Cranial Technologies, Inc $42.63 3
Seqirus USA Inc $25.54 1
SANOFI PASTEUR INC. $23.94 1
Acerta Pharma LLC $19.17 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $120.05 7
PY2019 $88.04 5
PY2020 $90.87 7
PY2021 $142.36 9
PY2022 $163.86 10
PY2023 $313.46 17
PY2024 $268.00 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $19.17 02/29/2024 Food and Beverage Undisputed 01/23/2026 1104426231 CMS
Cranial Technologies, Inc $14.10 04/23/2024 Food and Beverage Undisputed 01/23/2026 1082236176 CMS
Cranial Technologies, Inc $14.85 09/09/2024 Food and Beverage Undisputed 01/23/2026 1082236178 CMS
Cranial Technologies, Inc $13.68 11/27/2024 Food and Beverage Undisputed 01/23/2026 1082236174 CMS
GlaxoSmithKline, LLC. $14.98 02/09/2024 Food and Beverage Undisputed 01/23/2026 1116236134 CMS
GlaxoSmithKline, LLC. $19.26 05/21/2024 Food and Beverage Undisputed 01/23/2026 1116709227 CMS
GlaxoSmithKline, LLC. $15.75 06/27/2024 Food and Beverage Undisputed 01/23/2026 1116366716 CMS
GlaxoSmithKline, LLC. $19.12 11/05/2024 Food and Beverage Undisputed 01/23/2026 1116109689 CMS
GlaxoSmithKline, LLC. $17.06 12/04/2024 Food and Beverage Undisputed 01/23/2026 1116668920 CMS
PFIZER INC. $16.74 01/23/2024 Food and Beverage Undisputed 01/23/2026 1132007434 CMS
PFIZER INC. $25.05 02/14/2024 Food and Beverage Undisputed 01/23/2026 1131059617 CMS
PFIZER INC. $28.76 03/12/2024 Food and Beverage Undisputed 01/23/2026 1131231770 CMS
SANOFI PASTEUR INC. $23.94 09/18/2024 Food and Beverage Undisputed 01/23/2026 1128752123 CMS
Seqirus USA Inc $25.54 12/10/2024 Food and Beverage Undisputed 01/23/2026 1125630478 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.